Published in:
27-06-2023 | Melanoma | Melanoma
The Role of Clinicopathologic Nomograms for Melanoma in the Era of Gene Expression Profiling
Authors:
Raghav Tripathi, MD, MPH, Karen Larson, PhD, Graham Fowler, BA, John T. Vetto, MD, Jeremy S. Bordeaux, MD, MPH, Wesley Y. Yu, MD
Published in:
Annals of Surgical Oncology
|
Issue 11/2023
Login to get access
Excerpt
Sentinel lymph node biopsy (SLNB) status is an important prognostic indicator for determining candidacy for adjuvant therapy in patients with melanoma, but is best utilized in patients with a high pretest probability of regional metastasis.
1 Our study pooled data from the National Cancer Database (NCDB; 2004–2015) and the Surveillance, Epidemiology, and End Results [SEER] database (2000–2017) to develop and internally validate a nomogram to predict SLNB positivity in melanoma.
2 This nomogram was externally validated using data from a large tertiary referral center, and the model was found to be comparable in accuracy to other published clinicopathologic nomograms.
3‐5 …